Suppr超能文献

Cochrane 专栏:用于病毒性心肌炎的皮质类固醇

Cochrane Corner: Corticosteroids for viral myocarditis.

作者信息

Caldeira Daniel, Lopes Luís R, Vaz-Carneiro António, Costa João

机构信息

Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal; Unidade de Farmacologia Clínica, Instituto de Medicina Molecular, Lisboa, Portugal; Serviço de Cardiologia, Hospital Garcia de Orta, Almada, Portugal.

Serviço de Cardiologia, Hospital Garcia de Orta, Almada, Portugal; Centro de Cardiologia da Universidade de Lisboa, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal.

出版信息

Rev Port Cardiol. 2015 Jan;34(1):65-7. doi: 10.1016/j.repc.2014.08.006. Epub 2014 Dec 17.

Abstract

The causes of myocarditis are diverse, but a viral etiology is the most common. In this systematic review by the Cochrane Collaboration, the authors assessed the efficacy of corticosteroid therapy in patients with viral myocarditis. Eight randomized controlled trials with 719 patients (two trials in pediatric populations) were included for analysis. Pooled results did not show significant differences in mortality with the use of corticosteroids. Patients on corticosteroid therapy had significantly higher post-treatment left ventricular ejection fraction values compared to control. These results are limited by the significant heterogeneity associated with clinical trials. The best available evidence does not support the routine use of corticosteroids in patients with viral myocarditis.

摘要

心肌炎的病因多种多样,但病毒感染是最常见的病因。在Cochrane协作网的这项系统评价中,作者评估了皮质类固醇疗法对病毒性心肌炎患者的疗效。纳入了8项随机对照试验,共719例患者(其中两项试验为儿科人群)进行分析。汇总结果显示,使用皮质类固醇治疗的患者死亡率并无显著差异。与对照组相比,接受皮质类固醇治疗的患者治疗后左心室射血分数值显著更高。这些结果受到与临床试验相关的显著异质性的限制。现有最佳证据不支持对病毒性心肌炎患者常规使用皮质类固醇。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验